Clinical Trials Logo

Clinical Trial Summary

RAPHE is an open label randomized clinical trial to assess physical, biological and chemical methods of radial artery puncture hemostasis following coronary catheterization. A total of 600 subjects will be randomized in a 1:1:1 fashion to either the StatSeal, Axiostat or TR Band hemostasis devices. Follow-up of the subject will take place 60 days after the index procedure.


Clinical Trial Description

n/a


Study Design


NCT number NCT04857385
Study type Interventional
Source Semmelweis University Heart and Vascular Center
Contact István F Édes, MD PhD
Phone +36-1-458-6810
Email [email protected]
Status Recruiting
Phase N/A
Start date April 14, 2021
Completion date January 1, 2023